SCHEMBL77751

SCHEMBL77751

O=C(O)[C@H](CO)NP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5132096 1.00
SCHEMBL77750 1.00
SCHEMBL6470508 0.97
SCHEMBL3320474 0.79
SCHEMBL3320478 0.79
SCHEMBL14050302 0.78 TGFBR1 (0.60)
SCHEMBL27637802 0.78 TGFBR1 (0.60)
SCHEMBL21950137 0.78 TGFBR1 (0.60)
SCHEMBL8575470 0.77 TGFBR1 (0.58)
SCHEMBL8212102 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4395895-A1 NKP46-BINDING POLYPEPTIDES AND USES THEREOF Inhibrx, Inc. (US) 2024-07-10 EP claimed
WO-2024137677-A1 EXTRACELLULAR VESICLE-ENRICHED SECRETOME COMPOSITION DERIVED FROM INDUCED PLURIPOTENT STEM CELL DERIVED-MICROGLIA AND METHODS OF USE THEREOF FUJIFILM Holdings America Corporation (US) 2024-06-27 WO claimed
EP-4373854-A1 CD8-BINDING POLYPEPTIDES AND USES THEREOF Inhibrx, Inc. (US) 2024-05-29 EP claimed
CN-117940454-A NKp46 binding polypeptides and uses thereof 印希比股份有限公司 2024-04-26 CN claimed
US-20240101704-A1 MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND METHODS OF USING THE SAME Inhibrx, Inc. (US) 2024-03-28 US claimed
EP-4309512-A1 ONE SHOT PROCESS FOR THE SIMULTANEOUS EXTRACTION OF PHYTOCOMPLEX FROM AGRO-INDUSTRIAL PROCESSING WASTE AND LOADING IN EXTRACTIVE VESICLES AND THEIR USE Argiolas S.p.A. (IT) 2024-01-24 EP claimed
US-11867695-B2 Compositions and methods for detecting protease activity in biological systems CYTOMX THERAPEUTICS, INC. (US) 2024-01-09 US claimed
US-20230405176-A1 METHOD FOR PRODUCING WOUND DRESSINGS ON THE BASIS OF PHOSPHOLIPID-CONTAINING NANODISPERSIONS NSC PHARMA GMBH & CO. KG (DE) 2023-12-21 US claimed
US-20230348600-A1 CD28 SINGLE DOMAIN ANTIBODIES AND MULTIVALENT AND MULTISPECIFIC CONSTRUCTS THEREOF Inhibrx, Inc. (US) 2023-11-02 US claimed
US-11802158-B2 Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same CYTOMX THERAPEUTICS, INC. (US) 2023-10-31 US claimed
EP-0474833-A1 STABLE MICROBUBBLES SUSPENSIONS INJECTABLE INTO LIVING ORGANISMS. SINT SA (CH) 1992-03-18 EP claimed
US-5064817-A PHOSPHOLIPASE A2 INHIBITING COMPOSITIONS AND THEIR USE YISSUM RESEARCH DEVELOPMENT COMPANY OF HEBREW UNIVERSITY OF JERUSALEM (IL) 1991-11-12 US claimed
WO-1991015244-A2 STABLE MICROBUBBLES SUSPENSIONS INJECTABLE INTO LIVING ORGANISMS SINTETICA S.A. (CH) 1991-10-17 WO claimed
CN-1055298-A The stable microbubble of the organism of injectable into living SINT SA (CH) 1991-10-16 CN claimed
EP-0219922-B1 ANTHRACYCLINE ANTINEOPLASTIC AGENTS ENCAPSULATED IN PHOSPHOLIPID MICELLULAR PARTICLES VESTAR, INC. (US) 1991-07-24 EP claimed
EP-0315349-A1 Phospholipase A2 inhibiting compositions and their use YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1989-05-10 EP claimed
EP-0190050-A2 Method for preparing small vesicles using microemulsification VESTAR, INC. (US) 1986-08-06 EP claimed
EP-0065292-B1 PROCESS FOR THE STORAGE OF UNILAMELLAR PHOSPHOLIPID-VESICLES Gersonde, Klaus, Prof. Dr. (DE) 1986-01-08 EP claimed
EP-0068294-B1 A NEW ACARICIDAL COMPOSITION, PROCESSES FOR ITS PRODUCTION AND ITS USE A. Nattermann & Cie. GmbH (DE) 1985-12-18 EP claimed
EP-0068295-B1 A NEW HERBICIDAL COMPOSITION, PROCESSES FOR ITS PRODUCTION AND ITS USE A. Nattermann & Cie. GmbH (DE) 1985-08-28 EP claimed